The scientists of Norway are experimenting with Botox as a way to tackle obesity in a new wave of patient trials.
It’s theorised that if Botox is injected into the lining of the stomach that food will be absorbed by the body slower, leaving patients feeling fuller for longer – figures suggest food absorption will be limited by 50%.
The theory has been tested on some animals, and suggests that weight can be reduced by up to a third within about five weeks – results not entirely dissimilar to our Alevere Rapid Weight Loss Therapy.
In the U.K. a quarter of us are obese, with another large chunk also considered overweight. In extreme cases surgery is offered on the NHS, but generally doctors prescribe diet, exercise and drugs to help battle the bulge – apparently quite unsuccessfully.
Surgery to solve obesity can be one of two procedures: a gastric band fitted around part of the stomach to reduce its size, or gastric bypass, where surgery is used to physically and permanently limit stomach size.
For every 2,000 gastric band operations, a patient dies, though, and one in every 100 gastric bypass patients die. It’s risky business.
Botox, however, would be minimally invasive and less costly. The Botox would block signals from nerves to muscles to reduce muscle contraction. The injection would take place via endoscope.
In experiments done on lab rats at the Catholic University Rome, the animals treated lost 8.2% of their body weight and ate half as much food as the placebo rats.
However, similar research done at the American Gastroenterological Association dispute the findings. They argue that tests have been small and poorly designed. They are currently undertaking a study that seemingly proves the trick to regulating overeating is through the amygdala, citing psychology as the weight loss key.
Read the full article here.